Pharmaceutical

BioMarin Pharmaceutical gets grant for treatment of ado...

Reduce blood phenylalanine levels in adolescents with PKU using AvPAL variants. ...

Silence Therapeutics gets grant for compound for rna in...

Discover the groundbreaking patent by Silence Therapeutics Plc for a compound re...

Piramal Enterprises gets grant for pharmaceutical kit f...

Discover the groundbreaking patent by Piramal Enterprises Ltd for a pharmaceutic...

AstraZeneca champions early kidney disease diagnosis wi...

Early diagnosis of chronic kidney disease has both economic and environmental be...

Tacalyx extends seed funding round to raise over €14m

Cancer-focused biotech Tacalyx has extended its seed financing round to raise ov...

UK clinical trial sector must address prolonged timelin...

Experts highlighted the need to address a gap in UK regulatory timelines compare...

J&J-backed Bright Peak secures $90m to advance immunoco...

The funds will be used to advance PD1-IL18 immunoconjugate BPT567 into early-sta...

Amphastar Pharmaceuticals gets grant for medication con...

Discover how Amphastar Pharmaceuticals' patented medication delivery system prev...

Allscripts Healthcare Solutions gets grant for optimizi...

Discover how Allscripts Healthcare Solutions Inc's patented technologies optimiz...

Zydus Lifesciences gets grant for oral suspension of my...

Discover the innovative patent by Zydus Lifesciences Ltd for a pharmaceutical or...

ASCO24: Another win for Opdivo/Yervoy in first-line HCC...

The prognostic factor(s) driving outcomes at the initial stages of hepatocellula...

ChromaDex wins orphan designation for rare ataxia drug

The company will be filing an IND for nicotinamide riboside chloride (NRC), whic...

FDA admonishes Jiangsu Hengrui’s manufacturing site fol...

The US Food and Drug Administration (FDA) has criticised the state of Chinese ph...

Orano Med unveils radiopharma manufacturing plant in In...

The facility is expected to allow Orano Med to produce 5,000 doses of lead-212 b...

FDA AdCom to question efficacy and safety concerns with...

The FDA is looking to ask questions about a change of primary endpoint, treatmen...

Agomab wins FDA orphan drug status for idiopathic pulmo...

Agomab Therapeutics has now secured a US Food and Drug Administration (FDA) orph...